9th Circ. Refuses To Revive Novartis Jaw Injury Suit

Law360, Los Angeles (February 20, 2014, 10:34 PM EST) -- A Ninth Circuit panel on Thursday refused to revive a product liability lawsuit against Novartis Pharmaceuticals Corp. over jaw injuries allegedly related to bone drugs Aredia and Zometa, ruling that the plaintiff continued the drugs after his injury and could not prove they caused it.

In a memorandum opinion, the court affirmed a lower court’s grant of summary judgment to Novartis because plaintiff Duane Luttrell could not prove the drugs were the proximate cause of his jaw’s osteonecrosis.

Luttrell claimed Novartis did not provide proper warning...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Duane Luttrell v. Novartis Pharmaceuticals Corp.


Case Number

12-35893

Court

Appellate - 9th Circuit

Nature of Suit

4365 Personal Injury-Product Liability

Date Filed

October 29, 2012

Law Firms

Companies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.